Description

Peptide bioregulator (Glu-Asp-Arg / EDR) studied for neuroprotection

  1. Kozina LS. [Investigation of antihypoxic properties of short peptides]. Adv Gerontol. 2008;21(1):61-67. (Russian) PMID: 18546825
  2. Meshchaninov VN, et al. [Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome of the central nervous system in remission]. Adv Gerontol. 2015;28(1):62-67. (Russian) PMID: 26390612
  3. Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease. Molecules. 2020;26(1):159. PMID: 33396470 | DOI: 10.3390/molecules26010159

Note: Much of the primary work is in Russian-language gerontology journals and lacks DOIs.

Certificate of Analysis

Original laboratory report for Pinealon. Product and labeled strength matched. Vial lot/current-stock association has not been confirmed. Refer to the original report for laboratory findings.

Verify this batch

Print or download (PDF)

Serial: COA-1001276-FAZI · Integrity verified